Literature DB >> 29294187

Influence of Excipients on the Antimicrobial Activity of Tobramycin Against Pseudomonas aeruginosa Biofilms.

Tania Bahamondez-Canas1, Hugh D C Smyth2,3.   

Abstract

PURPOSE: It is unknown if inactive pharmaceutical ingredients influence the activity of antibiotics they are co-formulated with. Recently it was found that materials acting as carbon nutrient sources for bacteria can promote bacterial dispersion from a biofilm and/or reverse the persister state of a subpopulation of bacteria within the biofilms. Both can make bacteria more susceptible to antibiotics. Thus, the aim was to identify potential excipients to improve antibiotic activity in Pseudomonas aeruginosa biofilms.
METHODS: We screened 190 potential excipients alone, and in combination with tobramycin sulfate against P. aeruginosa (strain PAO1) grown planktonically or as biofilms. After the excipient screening stage, we investigated the effect of 10 selected excipients against a more virulent strain (luminescent strain UCBPP-PA14). Temporal changes in luminescence, as an indicator of bacterial proliferation, and surviving colony forming units (CFUs) from the treated PA14 biofilms were quantified.
RESULTS: Forty-eight materials tested caused a reduction of PAO1 proliferation either alone or combined with tobramycin. L-alanine (p < 0.05), D-alanine (p > 0.05), and N-acetyl-D-glucosaminitol (p > 0.05) improved the activity of tobramycin measured by PA14 luminometry. Additionally, L-alanine and succinic acid significantly reduced the survival of PA14 biofilms (p < 0.05).
CONCLUSIONS: L-alanine, succinic acid, and N-acetyl-D-glucosaminitol may be useful as antibiotic adjuvants in future tobramycin anti-biofilm formulations.

Entities:  

Keywords:  Biofilms; Cystic fibrosis; Excipients; Preformulation; Pseudomonas aeruginosa

Mesh:

Substances:

Year:  2018        PMID: 29294187     DOI: 10.1007/s11095-017-2301-5

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  59 in total

1.  Treatment with tobramycin solution for inhalation reduces hospitalizations in young CF subjects with mild lung disease.

Authors:  Timothy D Murphy; Ran D Anbar; Lucille A Lester; Samya Z Nasr; Bruce Nickerson; Donald R VanDevanter; Andrew A Colin
Journal:  Pediatr Pulmonol       Date:  2004-10

2.  How to optimize the drop plate method for enumerating bacteria.

Authors:  B Herigstad; M Hamilton; J Heersink
Journal:  J Microbiol Methods       Date:  2001-03-01       Impact factor: 2.363

3.  The impact of quorum sensing and swarming motility on Pseudomonas aeruginosa biofilm formation is nutritionally conditional.

Authors:  Joshua D Shrout; David L Chopp; Collin L Just; Morten Hentzer; Michael Givskov; Matthew R Parsek
Journal:  Mol Microbiol       Date:  2006-10-24       Impact factor: 3.501

Review 4.  Antimicrobial tolerance and the significance of persister cells in recalcitrant chronic wound biofilms.

Authors:  Steven L Percival; Katja E Hill; Sladjana Malic; David W Thomas; David W Williams
Journal:  Wound Repair Regen       Date:  2011 Jan-Feb       Impact factor: 3.617

Review 5.  Persister cells in biofilm associated infections.

Authors:  Brian P Conlon; Sarah E Rowe; Kim Lewis
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

Review 6.  Pathogenesis of the pseudomonas lung lesion in cystic fibrosis.

Authors:  R B Fick
Journal:  Chest       Date:  1989-07       Impact factor: 9.410

Review 7.  Metabolism and Pathogenicity of Pseudomonas aeruginosa Infections in the Lungs of Individuals with Cystic Fibrosis.

Authors:  Gregory C Palmer; Marvin Whiteley
Journal:  Microbiol Spectr       Date:  2015-08

8.  Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis.

Authors:  G M Nixon; D S Armstrong; R Carzino; J B Carlin; A Olinsky; C F Robertson; K Grimwood
Journal:  J Pediatr       Date:  2001-05       Impact factor: 4.406

Review 9.  Cystic fibrosis pathogenesis and the role of biofilms in persistent infection.

Authors:  J W Costerton
Journal:  Trends Microbiol       Date:  2001-02       Impact factor: 17.079

10.  Optimization of tetrazolium salt assay for Pseudomonas aeruginosa biofilm using microtiter plate method.

Authors:  Parastoo Sabaeifard; Ahya Abdi-Ali; Mohammad Reza Soudi; Rasoul Dinarvand
Journal:  J Microbiol Methods       Date:  2014-07-30       Impact factor: 2.363

View more
  2 in total

Review 1.  High-Throughput Approaches for the Identification of Pseudomonas aeruginosa Antivirulents.

Authors:  Donghoon Kang; Liyang Zhang; Natalia V Kirienko
Journal:  mBio       Date:  2021-05-04       Impact factor: 7.867

2.  Fostering Innovation in the Treatment of Chronic Polymicrobial Cystic Fibrosis-Associated Infections Exploring Aspartic Acid and Succinic Acid as Ciprofloxacin Adjuvants.

Authors:  Eduarda Silva; Rosana Monteiro; Tânia Grainha; Diana Alves; Maria Olivia Pereira; Ana Margarida Sousa
Journal:  Front Cell Infect Microbiol       Date:  2020-08-27       Impact factor: 5.293

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.